VIDEO: JAK inhibitors field is 'continuing to evolve'

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

The field of JAK inhibitors is continuing to evolve in terms of both data regarding new indications for different JAK inhibitors, a few new JAK inhibitors getting in the market, as well as new indications for old JAK inhibitors that we are familiar with, as well as, of course, since the dissemination of the ORAL Surveillance trial results in the New England Journal of Medicine last year. There's a lot of concerns, but, as well as evolving data on real world observational studies, for example, on the safety of JAK inhibitors continuing to evolve, so definitely a lot going on in this space.